Identification of an Exon 4-Deletion Variant of Epidermal Growth Factor Receptor with Increased Metastasis-Promoting Capacity
Authors:
- Min ZhouMZMin Zhou
- Bizhi ShiBSBizhi Shi
- Qingli ZhangQZQingli Zhang
- Hua JiangHJHua Jiang
- Yinghao SunYSYinghao Sun
- Jianhua LiuJLJianhua Liu
- Keke ZhouKZKeke Zhou
- Ming YaoMYMing Yao
- Jianren GuJGJianren Gu
- Shengli YangSYShengli Yang
- Ying MaoYMYing Mao
Open Access
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Epidermal growth factor receptor inhibitors in cancer treatment: advances, challenges and opportunitiesAnti-Cancer Drugs, 2009
- Detection of humoral response in patients with glioblastoma receiving EGFRvIII-KLH vaccinesJournal of Immunological Methods, 2008
- Survival of Cancer Cells Is Maintained by EGFR Independent of Its Kinase ActivityCancer Cell, 2008
- Mutant Epidermal Growth Factor Receptor (EGFRvIII) Contributes to Head and Neck Cancer Growth and Resistance to EGFR TargetingClinical Cancer Research, 2006
- Proliferation of Human Neuroblastomas Mediated by the Epidermal Growth Factor ReceptorCancer Research, 2005
- The regulation of cadherin-mediated adhesion by tyrosine phosphorylation/dephosphorylation of β-cateninCurrent Opinion in Cell Biology, 2005
- Glycosylation-induced Conformational Modification Positively Regulates Receptor-Receptor AssociationJournal of Biological Chemistry, 2001
- The autocrine loop of TGF-α/EGFR and brain tumorsJournal of Neuro-Oncology, 1997
- Transformational and altered signal transduction by a naturally occurring mutant EGF receptor.1996
- A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity.Proceedings of the National Academy of Sciences, 1994